Dresden Glaucoma and Treatment Study: Analysis to Assure the Quality of Follow-up and Therapy of Glaucoma Patients in a Tertiary University Hospital Glaucoma Service.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Glaucoma
- Sponsor
- Technische Universität Dresden
- Enrollment
- 10000
- Locations
- 1
- Primary Endpoint
- Follow-up intervals
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.
Detailed Description
The aim of the study is to evaluate the quality of follow-up and treatment by means of consecutive data collection and anonymised analysis of all glaucoma patients of a tertiary university hospital glaucoma service. Parameters being analyzed are: Age, sex, refraction, family history, known duration of glaucoma, highest intraocular pressure before treatment, systemic and topical medication, previous ocular surgery. 24h Goldmann-applanation tonometry, biomicroscopy, gonioscopy, Heidelberg Retinal Tomograph (HRT), glaucoma diagnosis with Scanning-Laser-Polarimetry (GDx), optical coherence tomography (OCT), Pentacam, Ocular Response Analyzer (ORA), Corvis ST (Corneal Visualization with the Scheimpflug Technology), perimetry
Investigators
Dr. Karin Pillunat
Dr. med.
Technische Universität Dresden
Eligibility Criteria
Inclusion Criteria
- •manifest glaucoma, ocular Hypertension, glaucoma suspect
Exclusion Criteria
- •under 18 years of age, corneal diseases
Outcomes
Primary Outcomes
Follow-up intervals
Time Frame: 20 years
To find the best follow-up intervals for glaucoma patients.
Secondary Outcomes
- Assessment of treatment quality(20 years)
- Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy(20 years)
- Assessment of intraocular pressure-lowering efficacy and number of participants with treatment-related adverse events as assessed by CTCAE v4.0 of glaucoma laser therapy of glaucoma surgery(20 years)